Clever, Personable, and Unconventional: A Look at Verve Therapeutics Class Action Lawsuit New York City, NY / Accesswire / September 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Verve Therapeutics, Inc. (“Verve Therapeutics” or “the Company”) (NASDAQ:VERV) and certain…
Foreign Diplomats Face Heightened Scrutiny in China By Laurie Chen, Yew Lun Tian and Brenda Goh BEIJING/SHANGHAI (Reuters) – Some diplomats in China say they are facing heightened scrutiny and interference from Chinese authorities, which is thwarting foreign officials’ efforts to re-engage with the country after three years of COVID-induced isolation. Twenty envoys from 12…
The Rollercoaster Ride of EVgo A Rough Patch for EVgo The past few weeks have been rough for EVgo (EVGO 0.29%), and by extension, for its shareholders. The stock’s now down more than 60% from its late-October peak, and touched a multimonth low just a few days ago. This significant drop in stock value has…
Dogecoin Rebounds at Support Level After 10-Day Decline The Rollercoaster Ride of Dogecoin Continues In the volatile world of cryptocurrency, few currencies have the ability to capture the attention of investors and traders quite like Dogecoin. Known for its meme-inspired origins and loyal community of supporters, Dogecoin has once again made headlines with its recent…
Welcome to the Future of Gold Mining in Africa Exciting Developments in the Democratic Republic of Congo Hey there, fellow gold enthusiasts! Have you heard the latest news from Barrick Gold Corporation? It looks like the future of gold mining in Africa is brighter than ever before. With very significant near-mine discoveries within trucking distance…
Merck Announces Phase 3 Clinical Trial for DLBCL Treatment A New Hope for Patients with Diffuse Large B-cell Lymphoma Rahway, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial evaluating zilovertamab vedotin in combination with rituximab plus cyclophosphamide,…
Theratechnologies: Q4 and Full Year 2024 Financial Results and Business Highlights Montreal, February 26, 2025 – Theratechnologies Inc., a leading specialty biopharmaceutical company, recently reported its financial results and business highlights for the fourth quarter and full year ended November 30, 2024. All figures are provided in US dollars. Business Highlights During the fourth quarter,…
Biloxi Shrimp Co. Celebrates Third Anniversary Introduction It’s time to break out the butter and cocktail sauce because Biloxi Shrimp Co. is turning three! Born on National Shrimp Day in 2020, this e-commerce shrimp purveyor has quickly made a name for itself as one of the largest direct-to-consumer shrimp sellers in the U.S. in just…
